Project Grant R01DK139214

Award Date 8/1/24
Completion Date 5/31/28
Dollars Obligated $1.4M
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $1,928,697 to investigate the quantitative mechanisms by which the gut microbiome impacts human energy balance. The primary awardee, Adventist Health System / Sunbelt Inc. (doing business as AdventHealth Orlando), will conduct a randomized controlled crossover feeding study to...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Duke University a $241,500 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to study the regulation of metabolic diseases by the human commensal bacterium Clostridium immunis. The overarching goal is to determine the mechanism by which an exopolysaccharide (EPS) secreted by C. immunis decreases visceral adiposity, a key risk factor for type 2 diabetes and...
The federal Project Grant award R15DK136098, "SEX DIFFERENCES IN HEDONIC FEEDING: THE ROLE OF THE GUT MICROBIOME," is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $416,456 award to Furman University aims to characterize sex differences in the gut microbiome and their impact on hedonic feeding, or food intake driven by pleasure rather than...
This Project Grant award, totaling $233,600.00 and spanning September 1, 2024 to June 30, 2027, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports high-throughput functional analyses of genetic drivers of inflammatory bowel disease (IBD), a debilitating condition characterized by chronic inflammation and erosion of intestinal functions. The...
This federal Project Grant award of $637,000.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research to explore the production and signaling properties of novel bile acids produced by the gut microbiome. The project aims to 1) define the microbiology of microbially conjugated bile acid (MCBA) production, 2) determine the agonist activity of MCBAs on the...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $1,970,885 to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to conduct research aimed at leveraging glycan-metabolite interactions to shape the structure and function of the gut microbiome. The key objectives are to: 1) Define the impact of butyrate on...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will provide $510,060 to support research on the role of the lac operon in Enterobacteriaceae colonization and disseminated infection in patients with liver disease. The primary objectives are to characterize the genetic adaptations that enable Escherichia coli to metabolize lactulose,...
This federal Project Grant award in the amount of $640,762.00 was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, with a start date of September 15, 2024 and an ultimate completion date of June 30, 2029, will fund research conducted by the Scripps Research Institute in La Jolla, California to investigate the interorgan communication mechanisms between...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will provide $516,648 over the period of Aug 28, 2024 to Feb 28, 2027 to The Leland Stanford Junior University to conduct research on understanding the mechanisms by which microbially-derived metabolites regulate host gut inflammation. The key products/services to be delivered under this award...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $533,907.00 to Rutgers, The State University to investigate the role of the epigenetic regulator TET3 in protecting intestinal epithelial cells against inflammatory stressors. The project aims to decipher the mechanisms by which TET3-mediated DNA oxidation and transcriptional...

This federal Project Grant award, titled "The Genomics and Consequences of Gut Bacterial Adaptation to High-Fat Diets," is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $1,363,668 award will support research conducted by The Trustees of Princeton University to investigate how gut bacteria adapt to high-fat diets and the subsequent impacts on host metabolic health. The 4-year project aims to: 1) identify genomic changes in gut bacteria under high-fat diets using evolve and re-sequence experiments, 2) quantify the effects of diet-induced plasmid transmission and proliferation, 3) measure the fitness advantages conferred by diet-adapted gut bacteria through microbiota competition experiments in germ-free mice, and 4) assess the impacts of diet-adapted gut bacteria on host gene expression, immune responses, and metabolic traits like adiposity. The findings are expected to elucidate the adaptive landscape experienced by gut microbiomes under high-fat dietary conditions and their consequences for host health.

Generated 7/1/25, 3:54 AM